Clinical study transparency programs are necessary for companies looking to disclose data and fully comply with state and federal regulations. Why else should your company create a transparency program? Join Darshan Kulkarni as he talks with guest Major Hoffman about six factors to consider before developing your transparency program. Plus, we’ll discuss why lay summaries are such valuable tools when communicating with patients.
A discussion with CRO CEO John Reites. Our discussion will explore decentralized clinical trials, the missing secret ingredient in clinical...
A discussion with health and clinical trial entrepreneur Zedrick Buhay on starting a clinical trial site, choosing studies and therapeutic...
A discussion on Project Management/Clinical Monitoring/Clinical Operations including on Clinical Development Training, recruitment and...
